Matches in SemOpenAlex for { <https://semopenalex.org/work/W3082018390> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W3082018390 endingPage "14" @default.
- W3082018390 startingPage "13" @default.
- W3082018390 abstract "The coronavirus disease 2019 (COVID-19) pandemic shut down the world in the spring of 2020. With that, the delivery of healthcare dramatically changed, perhaps forever. The pandemic has led to the need to distance physically, to minimize nonessential exposure, to acquire appropriate personal protective equipment for both providers and patients, to enhance sanitization and hygiene practices, and to cope with the additional costs of doing so. This crisis has made us rethink the status quo and reframe age-old debates. Many of the abrupt changes made during the pandemic in the name of safety have resulted in a more immersive and connected patient experience. For these reasons, many of these measures likely will continue well past the end of this crisis. Cataract surgeons have instituted many changes in practice during the COVID-19 pandemic. The move to more digitized and virtual healthcare delivery, online education tools, electronic intake, consolidating in-person visits, and increased spacing between patients have become the norm for cataract surgery. The one change in practice that could have the most significant benefit in reducing infection exposure risk is immediately sequential bilateral cataract surgery (ISBCS). Immediately sequential bilateral cataract surgery is less expensive, reduces personal protective equipment use, is more efficient, and provides faster binocular recovery of vision for the patient.1Rush S.W. Gerald A.E. Smith J.C. et al.Prospective analysis of outcomes and economic factors of same-day bilateral cataract surgery in the United States.J Cataract Refract Surg. 2015; 41: 732-739Crossref PubMed Google Scholar Immediately sequential bilateral cataract surgery has been debated for years, while the evidence in its support has grown over time.2Malvankar-Metha MS, Chen YN, Patel S et al. Immediate versus delayed sequential bilateral cataract surgery: a systematic review and meta-analysis. PLoS One. 10(6):e0131857.Google Scholar Hospitals achieve higher productivity and cost savings of more than 30% when performing ISBCS instead of delayed sequential bilateral cataracts surgery (DSBCS).3O’Bart D.P. Roberts H. Naderi K. Gormley J. Economic modelling of immediately sequential bilateral cataract surgery (ISBCS) in the National Health Service based on possible improvements in surgical efficiency.BMJ Open Ophthalmol. 2020; 5e000426Google Scholar, 4O’Brien J.J. Gonder J. Botz C. Chow K.Y. Arshinoff S.A. Immediately sequential bilateral cataract surgery versus delayed sequential bilateral cataract surgery: potential hospital cost savings.Can J Ophthalmol. 2010; 45: 596-601Abstract Full Text PDF PubMed Scopus (41) Google Scholar, 5Malvankar-Mehta M.S. Filek R. Iqbal M. et al.Immediately sequential bilateral cataract surgery: a cost-effective procedure.Can J Ophthalmol. 2013; 48: 482-488Abstract Full Text Full Text PDF PubMed Google Scholar The new normal of the COVID-19 era requires extra spacing, cleaning, and time between patients, resulting in increased costs. When considering the additional patient costs for travel, family and caregiver time, and absence from work with the extra postoperative visits and recovery requirements of DSBCS, the cost efficiency is even greater with ISBCS.6Leivo T. Sarikkola A.-U. Uusitalo R.J. et al.Simultaneous bilateral cataract surgery: economic analysis; Helsinki Simultaneous Bilateral Cataract Surgery Study report 2.J Cataract Refract Surg. 2011; 37: 1003-1008Crossref PubMed Scopus (71) Google Scholar The principles of safe ISBCS have been laid out by the International Society of Bilateral Cataract Surgeons. They include treating each eye as a separate independent procedure with new instruments, packs, gloves, gowns, drapes, and different lot numbers for pharmaceuticals and viscoelastics. Intracameral antibiotics are recommended. Caution is suggested in those eyes with a higher risk of refractive surprises (prior refractive surgery, extreme axial lengths) and increased risk of complications because of ocular comorbidities. If a complication occurring in the first eye of a planned ISBCS is unresolved at the time of surgery, it is advised to defer the second eye. Opponents who argue against ISBCS do so on 2 clinical points: the risk of bilateral postoperative endophthalmitis or toxic anterior segment syndrome and second-eye refractive planning. However, no evidence substantiates these fears. No cases of bilateral endophthalmitis have occurred in which the proper aseptic technique had been followed, nor have any cases of bilateral toxic anterior segment syndrome been reported with ISBCS. In a series of 95 606 ISBCS surgeries, no cases of bilateral endophthalmitis occurred. The overall infection rate was 1 in 16 890 (0.006%) with the use of intracameral antibiotics.7Arshinoff S.A. Bastianelli P.A. Incidence of postoperative endophthalmitis after immediate sequential bilateral cataract surgery.J Cataract Refract Surg. 2011; 37: 2105-2114Crossref PubMed Scopus (94) Google Scholar The theoretical risk of simultaneous bilateral postoperative endophthalmitis with proper aseptic technique is estimated to be less than 1 in 100 000 000. Ocular risks must be compared with systemic risks, as rare as either may be. Anesthesia and traveling risks are doubled with DSBCS versus ISBCS. Currently, the most feared and substantial systemic risk during the pandemic era is COVID-19 exposure. After the initial consultation and diagnostic testing, ISBCS reduces the number of patient visits (including waiting) and contact exposures by half. Avoiding exposure to other patients is critical for our elderly population with cataracts, whose risk of dying is higher with COVID-19 infection. In our opinion, this tips the safety balance further in favor of ISBCS.8Williamson E.J. Walker A.J. Bhaskaran K. et al.Factors associated COVID-19-reated death using OPENSAFELY.Nature. 2020; 584: 430-436Crossref PubMed Scopus (3332) Google Scholar Much has been written about the fear of performing ISBCS because of a need to adjust the intraocular lens power for the second eye after checking the result of the first eye. These concerns have been negated in the modern era of intraocular lens calculations, excluding patients with risk factors for refractive surprises. In addition, optimizing the ocular surface before surgery, using the latest optical biometers, applying validation criteria, and using the latest generation formulas, such as the Barrett Universal II, Hill-radial basis function, Olsen, and Kane methods, would be useful for enhancing refractive outcomes. Furthermore, adjusting the second eye intraocular lens power based on the first eye result is controversial, and it is not completely clear that it is beneficial in average eyes with modern generation formulas.9Landers J. Goggin M. An inter-eye comparison of refractive outcomes following cataract surgery.J Refract Surg. 2010; 26: 197-200Crossref PubMed Scopus (14) Google Scholar,10Jabbour J. Irwig L. Macaskill P. Hennessy M.P. Intraocular lens power in bilateral cataract surgery: whether adjusting for error of predicted refraction in the first eye improves prediction in the second eye.J Cataract Refract Surg. 2006; 32: 2091-2097Crossref PubMed Scopus (50) Google Scholar In support of ISBCS, a recent sizeable comparative study found that ISBCS performed no worse than DSBCS for postoperative best-corrected visual acuity, refractive error, or complications.11Herrinton L.J. Liu L. Alexeeff S. et al.Immediate sequential vs delayed sequential bilateral cataract surgery.Ophthalmology. 2017; 124: 1126-1135Abstract Full Text Full Text PDF PubMed Scopus (45) Google Scholar Beyond the clinical concerns, the fear of malpractice as an outlier with potential complications remains, as does reimbursement.12Neel S.T. A cost and policy analysis comparing immediate sequential cataract surgery and delayed sequential cataract surgery from the physician perspective in the United States.JAMA Ophthalmol. 2014; 132: 1359-1362Crossref PubMed Scopus (14) Google Scholar Both pose significant barriers to adoption, but times are changing. We are unaware of any successful malpractice claim based on the performance of ISBCS. The COVID-19 pandemic has forced and allowed us to push boundaries and reconsider priorities. Before the pandemic, ISBCS had been commonplace in many parts of the world and its use was growing in North America. Although more high-quality studies are needed, a growing body of evidence supports ISBCS. Improvements in technology, approach, and aseptic technique have made ISBCS a low-risk, precise, and cost-effective procedure. Patients and their families overwhelmingly express a preference for ISBCS when given a choice. In today’s COVID-19 world and beyond, patients should be given an informed option between ISBCS and DSBCS. It is time for our national societies to advocate for patient safety, quality of life, and preference and to resolve the financial penalty for performing the second-eye surgery on the same day as the first-eye surgery. With the COVID-19 crisis upon us, we must rethink the delivery of healthcare. Just like digitized medicine, virtual care, and artificial intelligence, ISBCS truly enhances care. The arguments for these paradigm shifts go well beyond the setting of a pandemic, but now more than ever is the time to start. Same Day Bilateral Cataract Surgery—Who Benefits?OphthalmologyVol. 128Issue 1PreviewThere was a time when decision making in health care followed a simple credo: If the treatment process was good for the patient, it was good for the doctor and good for the healthcare industry. That was a different day; times have changed. We are presently in an era when concerns about costs and convenience of healthcare delivery and third-party profit margins may, and sometimes do, seemingly exceed the interests of the individual patient. To my sense, routine simultaneous same-day bilateral cataract surgery (SDBCS) is emblematic of that shifting paradigm. Full-Text PDF" @default.
- W3082018390 created "2020-09-08" @default.
- W3082018390 creator A5000975562 @default.
- W3082018390 creator A5043649188 @default.
- W3082018390 creator A5087209951 @default.
- W3082018390 date "2021-01-01" @default.
- W3082018390 modified "2023-10-18" @default.
- W3082018390 title "Bilateral Same-Day Cataract Surgery: An Idea Whose Time Has Come #COVID-19" @default.
- W3082018390 cites W1858242814 @default.
- W3082018390 cites W1997642218 @default.
- W3082018390 cites W2010017232 @default.
- W3082018390 cites W2039412920 @default.
- W3082018390 cites W2067085204 @default.
- W3082018390 cites W2094872852 @default.
- W3082018390 cites W2124163651 @default.
- W3082018390 cites W2129195468 @default.
- W3082018390 cites W2144939109 @default.
- W3082018390 cites W2606474485 @default.
- W3082018390 cites W3038118023 @default.
- W3082018390 cites W3047144258 @default.
- W3082018390 doi "https://doi.org/10.1016/j.ophtha.2020.08.028" @default.
- W3082018390 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7462754" @default.
- W3082018390 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32888947" @default.
- W3082018390 hasPublicationYear "2021" @default.
- W3082018390 type Work @default.
- W3082018390 sameAs 3082018390 @default.
- W3082018390 citedByCount "32" @default.
- W3082018390 countsByYear W30820183902020 @default.
- W3082018390 countsByYear W30820183902021 @default.
- W3082018390 countsByYear W30820183902022 @default.
- W3082018390 countsByYear W30820183902023 @default.
- W3082018390 crossrefType "journal-article" @default.
- W3082018390 hasAuthorship W3082018390A5000975562 @default.
- W3082018390 hasAuthorship W3082018390A5043649188 @default.
- W3082018390 hasAuthorship W3082018390A5087209951 @default.
- W3082018390 hasBestOaLocation W30820183901 @default.
- W3082018390 hasConcept C116675565 @default.
- W3082018390 hasConcept C118487528 @default.
- W3082018390 hasConcept C126322002 @default.
- W3082018390 hasConcept C141071460 @default.
- W3082018390 hasConcept C159047783 @default.
- W3082018390 hasConcept C2775888743 @default.
- W3082018390 hasConcept C2779134260 @default.
- W3082018390 hasConcept C3006700255 @default.
- W3082018390 hasConcept C3007834351 @default.
- W3082018390 hasConcept C3008058167 @default.
- W3082018390 hasConcept C524204448 @default.
- W3082018390 hasConcept C71924100 @default.
- W3082018390 hasConceptScore W3082018390C116675565 @default.
- W3082018390 hasConceptScore W3082018390C118487528 @default.
- W3082018390 hasConceptScore W3082018390C126322002 @default.
- W3082018390 hasConceptScore W3082018390C141071460 @default.
- W3082018390 hasConceptScore W3082018390C159047783 @default.
- W3082018390 hasConceptScore W3082018390C2775888743 @default.
- W3082018390 hasConceptScore W3082018390C2779134260 @default.
- W3082018390 hasConceptScore W3082018390C3006700255 @default.
- W3082018390 hasConceptScore W3082018390C3007834351 @default.
- W3082018390 hasConceptScore W3082018390C3008058167 @default.
- W3082018390 hasConceptScore W3082018390C524204448 @default.
- W3082018390 hasConceptScore W3082018390C71924100 @default.
- W3082018390 hasFunder F4320321502 @default.
- W3082018390 hasFunder F4320322516 @default.
- W3082018390 hasFunder F4320328539 @default.
- W3082018390 hasFunder F4320332193 @default.
- W3082018390 hasFunder F4320332194 @default.
- W3082018390 hasFunder F4320332584 @default.
- W3082018390 hasFunder F4320332585 @default.
- W3082018390 hasIssue "1" @default.
- W3082018390 hasLocation W30820183901 @default.
- W3082018390 hasLocation W30820183902 @default.
- W3082018390 hasLocation W30820183903 @default.
- W3082018390 hasOpenAccess W3082018390 @default.
- W3082018390 hasPrimaryLocation W30820183901 @default.
- W3082018390 hasRelatedWork W3009669391 @default.
- W3082018390 hasRelatedWork W3036314732 @default.
- W3082018390 hasRelatedWork W3113664224 @default.
- W3082018390 hasRelatedWork W3176864053 @default.
- W3082018390 hasRelatedWork W3198183218 @default.
- W3082018390 hasRelatedWork W4200329650 @default.
- W3082018390 hasRelatedWork W4205317059 @default.
- W3082018390 hasRelatedWork W4206669628 @default.
- W3082018390 hasRelatedWork W4382894326 @default.
- W3082018390 hasRelatedWork W3127156785 @default.
- W3082018390 hasVolume "128" @default.
- W3082018390 isParatext "false" @default.
- W3082018390 isRetracted "false" @default.
- W3082018390 magId "3082018390" @default.
- W3082018390 workType "article" @default.